Volume 16 Number 17
April 2021

Volume 16 Number 17

In this issue of EuroIntervention, a State-of-the-Art on lipid-lowering therapy and PCI. In the coronary section: thin- versus thick-strut biodegradable polymer stents and the effectiveness of ultrathin-strut DES from the SCAAR registry. A mini focus on acute myocardial infarction with outcomes of STEMI  patients with COVID-19; the use of microvascular function assessment in determining STEMI treatment strategies; the study protocol of EURO-ICE, a trial of selective intracoronary hypothermia to improve primary PCI. In the valvular disease section: the clinical impact of re-clipping or surgery following failed transcatheter mitral valve repair; the predictors and management of transcatheter heart valve thrombosis after transcatheter mitral valve implantation.

Highlights from this issue

coronary
COVID-19 in STEMI
COVID-19 in STEMI
Rodriguez-Leor O, Cid Alvarez A, Perez de Prado A, Rossello X, Ojeda S, Serrador A, López-Palop R, Martin-Moreiras J, Rumoroso J, Cequier A, Ibáñez B, Cruz-González I, Romaguera R, Moreno R
April 20, 2021
DOI: 10.4244/EIJ-D-20-00935
valvular disease
Impact of intervention strategies after failed TMVR
Impact of intervention strategies after failed TMVR
Alessandrini H, Dreher A, Harr C, Wohlmuth P, Meincke F, Hakmi S, Ubben T, Kuck K, Hassan K, Willems S, Schmoeckel M, Geidel S
April 20, 2021
DOI: 10.4244/EIJ-D-20-01008
valvular disease
Thrombosis after transcatheter mitral valve implantation
Thrombosis after transcatheter mitral valve implantation
Kikoïne J, Urena M, Chong Nguyen C, Fischer Q, Carrasco J, Brochet E, Ducrocq G, Vahanian A, Iung B, Himbert D
April 20, 2021
DOI: 10.4244/EIJ-D-20-00991

State of the Art

State-of-the-Art Review
Lipid-lowering therapy and percutaneous coronary interventions
April 20, 2021 | 10.4244/EIJ-D-20-00999